News
Recent news about Panacea Capital and select portfolio companies
February 26, 2026
Podcast featuring Jean-Marie Cuillerot, Chief Medical Officer at Kainova Therapeutics – Closing the gap on rare diseases in 2026
February 26, 2026
Podcast featuring Jean-Marie Cuillerot, Chief Medical Officer at Kainova Therapeutics – Closing the gap on rare diseases in 2026
February 26, 2026
Evox Therapeutics Partners with Rett Syndrome Research Trust to Evaluate ExoEdit® Technology to Enable Gene Editing in Rett Syndrome
February 26, 2026
Evox Therapeutics Partners with Rett Syndrome Research Trust to Evaluate ExoEdit® Technology to Enable Gene Editing in Rett Syndrome
February 10, 2026
Kainova Therapeutics Secures $32M CAD to Accelerate Development of Immuno-Oncology and Inflammation Therapies
February 10, 2026
Kainova Therapeutics Secures $32M CAD to Accelerate Development of Immuno-Oncology and Inflammation Therapies
February 10, 2026
Kainova Therapeutics secures $CAD 32 million to accelerate the development of its immuno-oncology and inflammation portfolio.
February 10, 2026
Kainova Therapeutics secures $CAD 32 million to accelerate the development of its immuno-oncology and inflammation portfolio.
January 30, 2026
HiRO and Hallym University Sacred Heart Hospital Sign Strategic MOU to Advance Drug Development
Harvest Integrated Research Organization (HiRO), a boutique global CRO, is pleased to announce the signing…
January 30, 2026
HiRO and Hallym University Sacred Heart Hospital Sign Strategic MOU to Advance Drug Development
Harvest Integrated Research Organization (HiRO), a boutique global CRO, is pleased to announce the signing…